Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
Neurology
.
2017 Oct 31;89(18):1931.
doi: 10.1212/WNL.0000000000004593.
Authors
Serge Gauthier
1
,
Kok Pin Ng
2
,
Tharick A Pascoal
1
,
Sulantha Mathotaarachchi
3
,
Chang-Oh Chung
4
,
Andréa L Benedetti
1
2
1
3
4
1
5
6
2
1
,
Monica Shin
1
2
1
3
4
1
5
6
2
1
,
Min Su Kang
1
,
Xiaofeng Li
5
,
Maowen Ba
6
,
Nagaendran Kandiah
2
,
Pedro Rosa-Neto
1
Affiliations
1
Montreal.
2
Singapore.
3
Verdun, Canada.
4
Gwangju, Korea.
5
Chongqing.
6
Yantai, China.
PMID:
29084927
DOI:
10.1212/WNL.0000000000004593
No abstract available
Publication types
Comment
MeSH terms
Alzheimer Disease*
Humans